aluates Reports

$ 0.0

Automative

Global Eye Drug Market Insights, Forecast to 2030

Published Date: September 2024

Report Code: QYRE-Auto-5L7052

Global Eye Drug Market Insights and Forecast to 2028

BUY CHAPTERS

Global Eye Drug Market Insights, Forecast to 2030

Code: QYRE-Auto-5L7052

Report

September 2024

Pages:116

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Novartis

Bausch & Lomb

Laboratoire Riva

Jamp Pharma

Fresenius

Teva Pharmaceutical

Sandoz Inc

Greenstone

Mylan NV

GE Medical

Mint Pharmaceuticals

Laboratoires Thea

Taj Pharmaceuticals

Actavis

Apotex

Sun Pharma

Eye Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Eye Drug Market

The global Eye Drug market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Eye Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Eye Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Eye Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Eye Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Eye Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Eye Drug sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Eye Drug Market Report

Report Metric	Details
Report Name	Eye Drug Market
CAGR	5%
Segment by Type	Drops Tablet & Capsule
Segment by Application	Glaucoma Retinal Disease Bacterial?Infection Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	bausch Lomb, Laboratoire Riva, Jamp Pharma, Fresenius, Teva Pharmaceutical?, SANDOZ, Greenstone, Mylan, GE Medical, Mint Pharmaceuticals, Laboratoires Thea, Taj Pharmaceuticals, Actavis, APOTEX, Sun Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Eye Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Eye Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Eye Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Eye Drug Market report?

Ans: The main players in the Eye Drug Market are bausch Lomb, Laboratoire Riva, Jamp Pharma, Fresenius, Teva Pharmaceutical?, SANDOZ, Greenstone, Mylan, GE Medical, Mint Pharmaceuticals, Laboratoires Thea, Taj Pharmaceuticals, Actavis, APOTEX, Sun Pharma

What are the Application segmentation covered in the Eye Drug Market report?

Ans: The Applications covered in the Eye Drug Market report are Glaucoma, Retinal Disease, Bacterial?Infection, Other

What are the Type segmentation covered in the Eye Drug Market report?

Ans: The Types covered in the Eye Drug Market report are Drops, Tablet & Capsule

Recommended Reports

Ophthalmic Drugs

Eye Disease Therapeutics

Eye Drops & Delivery

1 Study Coverage

1.1 Eye Drug Product Introduction

1.2 Market by Type

1.2.1 Global Eye Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Drops

1.2.3 Tablet & Capsule

1.3 Market by Application

1.3.1 Global Eye Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Glaucoma

1.3.3 Retinal Disease

1.3.4 Bacterial?Infection

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Eye Drug Sales Estimates and Forecasts 2019-2030

2.2 Global Eye Drug Revenue by Region

2.2.1 Global Eye Drug Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Eye Drug Revenue by Region (2019-2024)

2.2.3 Global Eye Drug Revenue by Region (2025-2030)

2.2.4 Global Eye Drug Revenue Market Share by Region (2019-2030)

2.3 Global Eye Drug Sales Estimates and Forecasts 2019-2030

2.4 Global Eye Drug Sales by Region

2.4.1 Global Eye Drug Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Eye Drug Sales by Region (2019-2024)

2.4.3 Global Eye Drug Sales by Region (2025-2030)

2.4.4 Global Eye Drug Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Eye Drug Sales by Manufacturers

3.1.1 Global Eye Drug Sales by Manufacturers (2019-2024)

3.1.2 Global Eye Drug Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Eye Drug in 2023

3.2 Global Eye Drug Revenue by Manufacturers

3.2.1 Global Eye Drug Revenue by Manufacturers (2019-2024)

3.2.2 Global Eye Drug Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Eye Drug Revenue in 2023

3.3 Global Key Players of Eye Drug, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Eye Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Eye Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Eye Drug, Product Offered and Application

3.8 Global Key Manufacturers of Eye Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Eye Drug Sales by Type

4.1.1 Global Eye Drug Historical Sales by Type (2019-2024)

4.1.2 Global Eye Drug Forecasted Sales by Type (2025-2030)

4.1.3 Global Eye Drug Sales Market Share by Type (2019-2030)

4.2 Global Eye Drug Revenue by Type

4.2.1 Global Eye Drug Historical Revenue by Type (2019-2024)

4.2.2 Global Eye Drug Forecasted Revenue by Type (2025-2030)

4.2.3 Global Eye Drug Revenue Market Share by Type (2019-2030)

4.3 Global Eye Drug Price by Type

4.3.1 Global Eye Drug Price by Type (2019-2024)

4.3.2 Global Eye Drug Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Eye Drug Sales by Application

5.1.1 Global Eye Drug Historical Sales by Application (2019-2024)

5.1.2 Global Eye Drug Forecasted Sales by Application (2025-2030)

5.1.3 Global Eye Drug Sales Market Share by Application (2019-2030)

5.2 Global Eye Drug Revenue by Application

5.2.1 Global Eye Drug Historical Revenue by Application (2019-2024)

5.2.2 Global Eye Drug Forecasted Revenue by Application (2025-2030)

5.2.3 Global Eye Drug Revenue Market Share by Application (2019-2030)

5.3 Global Eye Drug Price by Application

5.3.1 Global Eye Drug Price by Application (2019-2024)

5.3.2 Global Eye Drug Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Eye Drug Market Size by Type

6.1.1 US & Canada Eye Drug Sales by Type (2019-2030)

6.1.2 US & Canada Eye Drug Revenue by Type (2019-2030)

6.2 US & Canada Eye Drug Market Size by Application

6.2.1 US & Canada Eye Drug Sales by Application (2019-2030)

6.2.2 US & Canada Eye Drug Revenue by Application (2019-2030)

6.3 US & Canada Eye Drug Market Size by Country

6.3.1 US & Canada Eye Drug Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Eye Drug Sales by Country (2019-2030)

6.3.3 US & Canada Eye Drug Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Eye Drug Market Size by Type

7.1.1 Europe Eye Drug Sales by Type (2019-2030)

7.1.2 Europe Eye Drug Revenue by Type (2019-2030)

7.2 Europe Eye Drug Market Size by Application

7.2.1 Europe Eye Drug Sales by Application (2019-2030)

7.2.2 Europe Eye Drug Revenue by Application (2019-2030)

7.3 Europe Eye Drug Market Size by Country

7.3.1 Europe Eye Drug Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Eye Drug Sales by Country (2019-2030)

7.3.3 Europe Eye Drug Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Eye Drug Market Size

8.1.1 China Eye Drug Sales (2019-2030)

8.1.2 China Eye Drug Revenue (2019-2030)

8.2 China Eye Drug Market Size by Application

8.2.1 China Eye Drug Sales by Application (2019-2030)

8.2.2 China Eye Drug Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Eye Drug Market Size by Type

9.1.1 Asia Eye Drug Sales by Type (2019-2030)

9.1.2 Asia Eye Drug Revenue by Type (2019-2030)

9.2 Asia Eye Drug Market Size by Application

9.2.1 Asia Eye Drug Sales by Application (2019-2030)

9.2.2 Asia Eye Drug Revenue by Application (2019-2030)

9.3 Asia Eye Drug Sales by Region

9.3.1 Asia Eye Drug Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Eye Drug Revenue by Region (2019-2030)

9.3.3 Asia Eye Drug Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Eye Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Eye Drug Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Eye Drug Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Eye Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Eye Drug Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Eye Drug Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Eye Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Eye Drug Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Eye Drug Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Eye Drug Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Overview

11.1.3 Pfizer Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Pfizer Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Recent Developments

11.2 Novartis

11.2.1 Novartis Company Information

11.2.2 Novartis Overview

11.2.3 Novartis Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Novartis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis Recent Developments

11.3 bausch Lomb

11.3.1 bausch Lomb Company Information

11.3.2 bausch Lomb Overview

11.3.3 bausch Lomb Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 bausch Lomb Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 bausch Lomb Recent Developments

11.4 Laboratoire Riva

11.4.1 Laboratoire Riva Company Information

11.4.2 Laboratoire Riva Overview

11.4.3 Laboratoire Riva Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Laboratoire Riva Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Laboratoire Riva Recent Developments

11.5 Jamp Pharma

11.5.1 Jamp Pharma Company Information

11.5.2 Jamp Pharma Overview

11.5.3 Jamp Pharma Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Jamp Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Jamp Pharma Recent Developments

11.6 Fresenius

11.6.1 Fresenius Company Information

11.6.2 Fresenius Overview

11.6.3 Fresenius Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Fresenius Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Fresenius Recent Developments

11.7 Teva Pharmaceutical?

11.7.1 Teva Pharmaceutical? Company Information

11.7.2 Teva Pharmaceutical? Overview

11.7.3 Teva Pharmaceutical? Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Teva Pharmaceutical? Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Teva Pharmaceutical? Recent Developments

11.8 SANDOZ

11.8.1 SANDOZ Company Information

11.8.2 SANDOZ Overview

11.8.3 SANDOZ Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 SANDOZ Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 SANDOZ Recent Developments

11.9 Greenstone

11.9.1 Greenstone Company Information

11.9.2 Greenstone Overview

11.9.3 Greenstone Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Greenstone Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Greenstone Recent Developments

11.10 Mylan

11.10.1 Mylan Company Information

11.10.2 Mylan Overview

11.10.3 Mylan Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Mylan Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Mylan Recent Developments

11.11 GE Medical

11.11.1 GE Medical Company Information

11.11.2 GE Medical Overview

11.11.3 GE Medical Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 GE Medical Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 GE Medical Recent Developments

11.12 Mint Pharmaceuticals

11.12.1 Mint Pharmaceuticals Company Information

11.12.2 Mint Pharmaceuticals Overview

11.12.3 Mint Pharmaceuticals Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Mint Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Mint Pharmaceuticals Recent Developments

11.13 Laboratoires Thea

11.13.1 Laboratoires Thea Company Information

11.13.2 Laboratoires Thea Overview

11.13.3 Laboratoires Thea Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Laboratoires Thea Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Laboratoires Thea Recent Developments

11.14 Taj Pharmaceuticals

11.14.1 Taj Pharmaceuticals Company Information

11.14.2 Taj Pharmaceuticals Overview

11.14.3 Taj Pharmaceuticals Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.14.4 Taj Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Taj Pharmaceuticals Recent Developments

11.15 Actavis

11.15.1 Actavis Company Information

11.15.2 Actavis Overview

11.15.3 Actavis Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.15.4 Actavis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Actavis Recent Developments

11.16 APOTEX

11.16.1 APOTEX Company Information

11.16.2 APOTEX Overview

11.16.3 APOTEX Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.16.4 APOTEX Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 APOTEX Recent Developments

11.17 Sun Pharma

11.17.1 Sun Pharma Company Information

11.17.2 Sun Pharma Overview

11.17.3 Sun Pharma Eye Drug Sales, Price, Revenue and Gross Margin (2019-2024)

11.17.4 Sun Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Sun Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Eye Drug Industry Chain Analysis

12.2 Eye Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Eye Drug Production Mode & Process

12.4 Eye Drug Sales and Marketing

12.4.1 Eye Drug Sales Channels

12.4.2 Eye Drug Distributors

12.5 Eye Drug Customers

13 Market Dynamics

13.1 Eye Drug Industry Trends

13.2 Eye Drug Market Drivers

13.3 Eye Drug Market Challenges

13.4 Eye Drug Market Restraints

14 Key Findings in The Global Eye Drug Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Novartis

Bausch & Lomb

Laboratoire Riva

Jamp Pharma

Fresenius

Teva Pharmaceutical

Sandoz Inc

Greenstone

Mylan NV

GE Medical

Mint Pharmaceuticals

Laboratoires Thea

Taj Pharmaceuticals

Actavis

Apotex

Sun Pharma

List of Tables

Table 1. Global Eye Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Drops

Table 3. Major Manufacturers of Tablet & Capsule

Table 4. Global Eye Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Eye Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Eye Drug Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Eye Drug Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Eye Drug Revenue Market Share by Region (2019-2024)

Table 9. Global Eye Drug Revenue Market Share by Region (2025-2030)

Table 10. Global Eye Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Eye Drug Sales by Region (2019-2024) & (MT)

Table 12. Global Eye Drug Sales by Region (2025-2030) & (MT)

Table 13. Global Eye Drug Sales Market Share by Region (2019-2024)

Table 14. Global Eye Drug Sales Market Share by Region (2025-2030)

Table 15. Global Eye Drug Sales by Manufacturers (2019-2024) & (MT)

Table 16. Global Eye Drug Sales Share by Manufacturers (2019-2024)

Table 17. Global Eye Drug Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Eye Drug Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Eye Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Eye Drug Price by Manufacturers 2019-2024 (USD/Kg)

Table 21. Global Eye Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Eye Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eye Drug as of 2023)

Table 23. Global Key Manufacturers of Eye Drug, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Eye Drug, Product Offered and Application

Table 25. Global Key Manufacturers of Eye Drug, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Eye Drug Sales by Type (2019-2024) & (MT)

Table 28. Global Eye Drug Sales by Type (2025-2030) & (MT)

Table 29. Global Eye Drug Sales Share by Type (2019-2024)

Table 30. Global Eye Drug Sales Share by Type (2025-2030)

Table 31. Global Eye Drug Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Eye Drug Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Eye Drug Revenue Share by Type (2019-2024)

Table 34. Global Eye Drug Revenue Share by Type (2025-2030)

Table 35. Eye Drug Price by Type (2019-2024) & (USD/Kg)

Table 36. Global Eye Drug Price Forecast by Type (2025-2030) & (USD/Kg)

Table 37. Global Eye Drug Sales by Application (2019-2024) & (MT)

Table 38. Global Eye Drug Sales by Application (2025-2030) & (MT)

Table 39. Global Eye Drug Sales Share by Application (2019-2024)

Table 40. Global Eye Drug Sales Share by Application (2025-2030)

Table 41. Global Eye Drug Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Eye Drug Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Eye Drug Revenue Share by Application (2019-2024)

Table 44. Global Eye Drug Revenue Share by Application (2025-2030)

Table 45. Eye Drug Price by Application (2019-2024) & (USD/Kg)

Table 46. Global Eye Drug Price Forecast by Application (2025-2030) & (USD/Kg)

Table 47. US & Canada Eye Drug Sales by Type (2019-2024) & (MT)

Table 48. US & Canada Eye Drug Sales by Type (2025-2030) & (MT)

Table 49. US & Canada Eye Drug Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Eye Drug Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Eye Drug Sales by Application (2019-2024) & (MT)

Table 52. US & Canada Eye Drug Sales by Application (2025-2030) & (MT)

Table 53. US & Canada Eye Drug Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Eye Drug Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Eye Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Eye Drug Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Eye Drug Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Eye Drug Sales by Country (2019-2024) & (MT)

Table 59. US & Canada Eye Drug Sales by Country (2025-2030) & (MT)

Table 60. Europe Eye Drug Sales by Type (2019-2024) & (MT)

Table 61. Europe Eye Drug Sales by Type (2025-2030) & (MT)

Table 62. Europe Eye Drug Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Eye Drug Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Eye Drug Sales by Application (2019-2024) & (MT)

Table 65. Europe Eye Drug Sales by Application (2025-2030) & (MT)

Table 66. Europe Eye Drug Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Eye Drug Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Eye Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Eye Drug Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Eye Drug Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Eye Drug Sales by Country (2019-2024) & (MT)

Table 72. Europe Eye Drug Sales by Country (2025-2030) & (MT)

Table 73. China Eye Drug Sales by Type (2019-2024) & (MT)

Table 74. China Eye Drug Sales by Type (2025-2030) & (MT)

Table 75. China Eye Drug Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Eye Drug Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Eye Drug Sales by Application (2019-2024) & (MT)

Table 78. China Eye Drug Sales by Application (2025-2030) & (MT)

Table 79. China Eye Drug Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Eye Drug Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Eye Drug Sales by Type (2019-2024) & (MT)

Table 82. Asia Eye Drug Sales by Type (2025-2030) & (MT)

Table 83. Asia Eye Drug Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Eye Drug Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Eye Drug Sales by Application (2019-2024) & (MT)

Table 86. Asia Eye Drug Sales by Application (2025-2030) & (MT)

Table 87. Asia Eye Drug Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Eye Drug Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Eye Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Eye Drug Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Eye Drug Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Eye Drug Sales by Region (2019-2024) & (MT)

Table 93. Asia Eye Drug Sales by Region (2025-2030) & (MT)

Table 94. Middle East, Africa and Latin America Eye Drug Sales by Type (2019-2024) & (MT)

Table 95. Middle East, Africa and Latin America Eye Drug Sales by Type (2025-2030) & (MT)

Table 96. Middle East, Africa and Latin America Eye Drug Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Eye Drug Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Eye Drug Sales by Application (2019-2024) & (MT)

Table 99. Middle East, Africa and Latin America Eye Drug Sales by Application (2025-2030) & (MT)

Table 100. Middle East, Africa and Latin America Eye Drug Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Eye Drug Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Eye Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Eye Drug Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Eye Drug Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Eye Drug Sales by Country (2019-2024) & (MT)

Table 106. Middle East, Africa and Latin America Eye Drug Sales by Country (2025-2030) & (MT)

Table 107. Pfizer Company Information

Table 108. Pfizer Description and Major Businesses

Table 109. Pfizer Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 110. Pfizer Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Pfizer Recent Developments

Table 112. Novartis Company Information

Table 113. Novartis Description and Major Businesses

Table 114. Novartis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 115. Novartis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Novartis Recent Developments

Table 117. bausch Lomb Company Information

Table 118. bausch Lomb Description and Major Businesses

Table 119. bausch Lomb Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 120. bausch Lomb Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. bausch Lomb Recent Developments

Table 122. Laboratoire Riva Company Information

Table 123. Laboratoire Riva Description and Major Businesses

Table 124. Laboratoire Riva Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 125. Laboratoire Riva Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Laboratoire Riva Recent Developments

Table 127. Jamp Pharma Company Information

Table 128. Jamp Pharma Description and Major Businesses

Table 129. Jamp Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 130. Jamp Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Jamp Pharma Recent Developments

Table 132. Fresenius Company Information

Table 133. Fresenius Description and Major Businesses

Table 134. Fresenius Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 135. Fresenius Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Fresenius Recent Developments

Table 137. Teva Pharmaceutical? Company Information

Table 138. Teva Pharmaceutical? Description and Major Businesses

Table 139. Teva Pharmaceutical? Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 140. Teva Pharmaceutical? Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Teva Pharmaceutical? Recent Developments

Table 142. SANDOZ Company Information

Table 143. SANDOZ Description and Major Businesses

Table 144. SANDOZ Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 145. SANDOZ Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. SANDOZ Recent Developments

Table 147. Greenstone Company Information

Table 148. Greenstone Description and Major Businesses

Table 149. Greenstone Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 150. Greenstone Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Greenstone Recent Developments

Table 152. Mylan Company Information

Table 153. Mylan Description and Major Businesses

Table 154. Mylan Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 155. Mylan Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Mylan Recent Developments

Table 157. GE Medical Company Information

Table 158. GE Medical Description and Major Businesses

Table 159. GE Medical Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 160. GE Medical Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. GE Medical Recent Developments

Table 162. Mint Pharmaceuticals Company Information

Table 163. Mint Pharmaceuticals Description and Major Businesses

Table 164. Mint Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 165. Mint Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Mint Pharmaceuticals Recent Developments

Table 167. Laboratoires Thea Company Information

Table 168. Laboratoires Thea Description and Major Businesses

Table 169. Laboratoires Thea Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 170. Laboratoires Thea Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Laboratoires Thea Recent Developments

Table 172. Taj Pharmaceuticals Company Information

Table 173. Taj Pharmaceuticals Description and Major Businesses

Table 174. Taj Pharmaceuticals Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 175. Taj Pharmaceuticals Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 176. Taj Pharmaceuticals Recent Developments

Table 177. Actavis Company Information

Table 178. Actavis Description and Major Businesses

Table 179. Actavis Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 180. Actavis Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 181. Actavis Recent Developments

Table 182. APOTEX Company Information

Table 183. APOTEX Description and Major Businesses

Table 184. APOTEX Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 185. APOTEX Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 186. APOTEX Recent Developments

Table 187. Sun Pharma Company Information

Table 188. Sun Pharma Description and Major Businesses

Table 189. Sun Pharma Eye Drug Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 190. Sun Pharma Eye Drug Product Model Numbers, Pictures, Descriptions and Specifications

Table 191. Sun Pharma Recent Developments

Table 192. Key Raw Materials Lists

Table 193. Raw Materials Key Suppliers Lists

Table 194. Eye Drug Distributors List

Table 195. Eye Drug Customers List

Table 196. Eye Drug Market Trends

Table 197. Eye Drug Market Drivers

Table 198. Eye Drug Market Challenges

Table 199. Eye Drug Market Restraints

Table 200. Research Programs/Design for This Report

Table 201. Key Data Information from Secondary Sources

Table 202. Key Data Information from Primary Sources

List of Figures

Figure 1. Eye Drug Product Picture

Figure 2. Global Eye Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Eye Drug Market Share by Type in 2023 & 2030

Figure 4. Drops Product Picture

Figure 5. Tablet & Capsule Product Picture

Figure 6. Global Eye Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Eye Drug Market Share by Application in 2023 & 2030

Figure 8. Glaucoma

Figure 9. Retinal Disease

Figure 10. Bacterial?Infection

Figure 11. Other

Figure 12. Eye Drug Report Years Considered

Figure 13. Global Eye Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Eye Drug Revenue 2019-2030 (US$ Million)

Figure 15. Global Eye Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Eye Drug Revenue Market Share by Region (2019-2030)

Figure 17. Global Eye Drug Sales 2019-2030 ((MT)

Figure 18. Global Eye Drug Sales Market Share by Region (2019-2030)

Figure 19. US & Canada Eye Drug Sales YoY (2019-2030) & (MT)

Figure 20. US & Canada Eye Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 21. Europe Eye Drug Sales YoY (2019-2030) & (MT)

Figure 22. Europe Eye Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 23. China Eye Drug Sales YoY (2019-2030) & (MT)

Figure 24. China Eye Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 25. Asia (excluding China) Eye Drug Sales YoY (2019-2030) & (MT)

Figure 26. Asia (excluding China) Eye Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Eye Drug Sales YoY (2019-2030) & (MT)

Figure 28. Middle East, Africa and Latin America Eye Drug Revenue YoY (2019-2030) & (US$ Million)

Figure 29. The Eye Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 30. The Top 5 and 10 Largest Manufacturers of Eye Drug in the World: Market Share by Eye Drug Revenue in 2023

Figure 31. Global Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 32. Global Eye Drug Sales Market Share by Type (2019-2030)

Figure 33. Global Eye Drug Revenue Market Share by Type (2019-2030)

Figure 34. Global Eye Drug Sales Market Share by Application (2019-2030)

Figure 35. Global Eye Drug Revenue Market Share by Application (2019-2030)

Figure 36. US & Canada Eye Drug Sales Market Share by Type (2019-2030)

Figure 37. US & Canada Eye Drug Revenue Market Share by Type (2019-2030)

Figure 38. US & Canada Eye Drug Sales Market Share by Application (2019-2030)

Figure 39. US & Canada Eye Drug Revenue Market Share by Application (2019-2030)

Figure 40. US & Canada Eye Drug Revenue Share by Country (2019-2030)

Figure 41. US & Canada Eye Drug Sales Share by Country (2019-2030)

Figure 42. U.S. Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 43. Canada Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 44. Europe Eye Drug Sales Market Share by Type (2019-2030)

Figure 45. Europe Eye Drug Revenue Market Share by Type (2019-2030)

Figure 46. Europe Eye Drug Sales Market Share by Application (2019-2030)

Figure 47. Europe Eye Drug Revenue Market Share by Application (2019-2030)

Figure 48. Europe Eye Drug Revenue Share by Country (2019-2030)

Figure 49. Europe Eye Drug Sales Share by Country (2019-2030)

Figure 50. Germany Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 51. France Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 52. U.K. Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 53. Italy Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 54. Russia Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 55. China Eye Drug Sales Market Share by Type (2019-2030)

Figure 56. China Eye Drug Revenue Market Share by Type (2019-2030)

Figure 57. China Eye Drug Sales Market Share by Application (2019-2030)

Figure 58. China Eye Drug Revenue Market Share by Application (2019-2030)

Figure 59. Asia Eye Drug Sales Market Share by Type (2019-2030)

Figure 60. Asia Eye Drug Revenue Market Share by Type (2019-2030)

Figure 61. Asia Eye Drug Sales Market Share by Application (2019-2030)

Figure 62. Asia Eye Drug Revenue Market Share by Application (2019-2030)

Figure 63. Asia Eye Drug Revenue Share by Region (2019-2030)

Figure 64. Asia Eye Drug Sales Share by Region (2019-2030)

Figure 65. Japan Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 66. South Korea Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 67. China Taiwan Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 68. Southeast Asia Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 69. India Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Eye Drug Sales Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Eye Drug Revenue Market Share by Type (2019-2030)

Figure 72. Middle East, Africa and Latin America Eye Drug Sales Market Share by Application (2019-2030)

Figure 73. Middle East, Africa and Latin America Eye Drug Revenue Market Share by Application (2019-2030)

Figure 74. Middle East, Africa and Latin America Eye Drug Revenue Share by Country (2019-2030)

Figure 75. Middle East, Africa and Latin America Eye Drug Sales Share by Country (2019-2030)

Figure 76. Brazil Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 77. Mexico Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 78. Turkey Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 79. Israel Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 80. GCC Countries Eye Drug Revenue (2019-2030) & (US$ Million)

Figure 81. Eye Drug Value Chain

Figure 82. Eye Drug Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharma Ophthalmic Market Research Report 2025

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Glaucoma Medications Market Insights Forecast to 2030

Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Glaucoma Drugs Market Research Report 2024

Global Eye Inflammation Treatment Market Research Report 2025

Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024

Global Eyedrops for Cataract Market Insights Forecast to 2030

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Global Retinal Disorder Treatment Market Research Report 2024

Eye Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Glaucoma Eyedrops Market Insights Forecast to 2030

Global Ocular Drug Delivery Devices Market Research Report 2025

Eye Drops and Eye Ointments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Eye Ointments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Computer Vision in Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions